Après l'effort, le réconfort articulaire!
Food supplement declared in France, decision dated 17 February 2026
Après l'effort, le réconfort articulaire!, from Le repos du pèlerin, is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Betula pendula 0.2 mg per day, Fraxinus excelsior 0.2 mg per day, Filipendula ulmaria 0.2 mg per day, Ajuga reptans 0.2 mg per day, Ribes nigrum 0.2 mg per day. 2 rules of use apply to its ingredients (limits and warnings).
- Brand
- not provided
- Food business operator placing the product on the market
- Le repos du pèlerin
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Spray
- Daily dose
- 3 à 5 sprays
- Directions for use
- 3 à 5 sprays par jour
- Intended populations
- Men and women aged 18 and over
- Not recommended (according to the manufacturer)
- Adolescents (under 18), Breastfeeding women, Allergy to salicylate derivatives, Children (under 12), Pregnant women, Taking anticoagulants
- Objectives stated by the manufacturer (these are not authorised claims)
- Joints, Sport
Declaration 357165, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Betula pendula Roth | Bourgeon | Macérât hydroglycériné | 0.2 mg |
| Fraxinus excelsior L. | Bourgeon | Macérât hydroglycériné | 0.2 mg |
| Filipendula ulmaria (L.) Maxim. | Sommités fleuries | Alcoolature | 0.2 mg |
| Ajuga reptans L. | Parties aériennes | Alcoolature | 0.2 mg |
| Ribes nigrum L. | Bourgeon | Macérât hydroglycériné | 0.2 mg |
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Has the product changed? Photograph the packaging.
Label warnings
Ne pas utiliser comme substitut alimentaire, tenir hors de portée des jeunes enfants / déconseillé aux femmes enceintes et allaitantes, réservé aux adultes, déconseillé aux personnes souffrant d’allergie aux dérivés salicylés et/ou sous traitement anti-coagulant
Regulatory points
- Conditions légales
Betula pendula Roth: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux personnes souffrant d'allergie aux dérivés salicylés
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
- Conditions légales
Filipendula ulmaria (L.) Maxim.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux personnes souffrant d'allergie aux dérivés salicylés.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Betula pendula Roth
Read the warning, when it applies and the studies cited
Birch
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have kidney or cardiovascular disorders (Brinker 2010; Bradley 2006; ESCOP 2003; Blumenthal et al. 1998).
Sources cited by Health Canada (4)
- Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Riggins C, Rister R, editors. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Austin (TX): American Botanical Council; 1998.
- Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 2. Bournemouth (UK): British Herbal Medicine Association; 2006.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (Brinker 2010).
Sources cited by Health Canada (1)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Après l'effort, le réconfort articulaire!: composition and regulation”, https://compoatlas.com/en/supplements/products/357165-apres-l-effort-le-reconfort-articulaire, updated 15 November 2026.